C07D 209/30
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
C07D209/30 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 2,672 US grants and 2,487 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,672
- Published applications
- 2,487
- Assignees
- 1,191
- Inventors
- 8,131
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 21 | 0 |
| 1977 | 26 | 0 |
| 1978 | 27 | 0 |
| 1979 | 21 | 0 |
| 1980 | 23 | 0 |
| 1981 | 18 | 0 |
| 1982 | 17 | 0 |
| 1983 | 16 | 0 |
| 1984 | 30 | 0 |
| 1985 | 28 | 0 |
| 1986 | 40 | 0 |
| 1987 | 39 | 0 |
| 1988 | 30 | 0 |
| 1989 | 54 | 0 |
| 1990 | 43 | 0 |
| 1991 | 32 | 0 |
| 1992 | 42 | 0 |
| 1993 | 49 | 0 |
| 1994 | 33 | 0 |
| 1995 | 36 | 0 |
| 1996 | 55 | 0 |
| 1997 | 68 | 0 |
| 1998 | 55 | 0 |
| 1999 | 55 | 0 |
| 2000 | 44 | 0 |
| 2001 | 81 | 13 |
| 2002 | 60 | 78 |
| 2003 | 63 | 127 |
| 2004 | 77 | 162 |
| 2005 | 58 | 140 |
| 2006 | 96 | 142 |
| 2007 | 95 | 140 |
| 2008 | 81 | 126 |
| 2009 | 81 | 134 |
| 2010 | 101 | 132 |
| 2011 | 80 | 96 |
| 2012 | 82 | 70 |
| 2013 | 59 | 81 |
| 2014 | 74 | 81 |
| 2015 | 77 | 103 |
| 2016 | 62 | 83 |
| 2017 | 80 | 87 |
| 2018 | 53 | 75 |
| 2019 | 74 | 70 |
| 2020 | 59 | 89 |
| 2021 | 50 | 70 |
| 2022 | 54 | 79 |
| 2023 | 48 | 107 |
| 2024 | 47 | 82 |
| 2025 | 48 | 63 |
| 2026 | 30 | 57 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Inhibitors of tyrosine kinase22 Sep 2026US 12,740,982 B2BridGene Biosciences, Inc.
- Composition for forming organic film, patterning process, and compound and polymer for forming organic film8 Sep 2026US 12,730,377 B2Shin-Etsu Chemical Co., Ltd.
- Bacterial efflux pump inhibitors1 Sep 2026US 12,723,040 B2Taxis Pharmaceuticals, Inc.
- (1 h-indol-5-yl)acrylamide derivatives as inhibitors of TEAD proteins and the hippo-YAP1/TAZ signaling cascade for the treatment of cancer28 Jul 2026US 12,692,230 B2Sanofi
- Fused pyrrolidine-2-one herbicidal compounds1 Oct 2026US 2026/0293894 A1Syngenta Crop Protection AG
- Non-Peptide Small Molecule FGF14:Nav1.6 Channel Complex Protein-Protein Interaction Modulators1 Oct 2026US 2026/0297027 A1Board of Regents, The University of Texas System
- Trpv1 agonist and uses thereof17 Sep 2026US 2026/0274802 A1SciTherm Therapeutics Corporation
- Compounds for the treatment of hiv10 Sep 2026US 2026/0265194 A1Dana-Farber Cancer Institute, Inc.
- Sarm1 modulators, preparations, and uses thereof10 Sep 2026US 2026/0265195 A1Sironax Ltd.
Most cited
By later US patents
- 3-heteroaryl-2-indolinone compounds for the treatment of disease265US 5,792,783 ASugen, Inc. · 1998
- Indole analogs of mevalonolactone and derivatives thereof174US 5,354,772 ASandoz Pharm. Corp. · 1994
- 3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease169US 5,883,113 ASugen, Inc. · 1999
- 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease168US 5,886,020 ASugen, Inc. · 1999
- 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease165US 5,834,504 ASugen, Inc. · 1998